Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.2133226742998
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85. doi:10.1056/NEJM20000713343020110891514
   PubMed Web of Science ®Google Scholar
• Valle L. Recent discoveries in the genetics of familial colorectal cancer and polyposis. Clin Gastroenterol Hepatol. 2017;15(6):809–819. doi:10.1016/j.cgh.2016.09.14827712984
   PubMed Web of Science ®Google Scholar
• Lorans M, Dow E, Macrae FA, Winship IM, Buchanan DD. Update on hereditary colorectal cancer: improving the clinical utility of multigene panel testing. Clin Colorectal Cancer. 2018;17(2):e293–e305. doi:10.1016/j.clcc.2018.01.00129454559
   PubMed Web of Science ®Google Scholar
• Stoffel EM, Mangu PB, Gruber SB, et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;33(2):209–217. doi:10.1200/JCO.2014.58.132225452455
   PubMed Web of Science ®Google Scholar
• Balmana J, Balaguer F, Cervantes A, Arnold D. Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2013;24(Suppl 6):vi73–80. doi:10.1093/annonc/mdt20923813931
   PubMed Web of Science ®Google Scholar
• Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348(10):919–932. doi:10.1056/NEJMra01224212621137
   PubMed Web of Science ®Google Scholar
• Obuch JC, Ahnen DJ. Colorectal cancer: genetics is changing everything. Gastroenterol Clin North Am. 2016;45(3):459–476. doi:10.1016/j.gtc.2016.04.00527546843
   PubMed Web of Science ®Google Scholar
• Pearlman, R, Frankel WL, Swanson B, et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017;3(4):464–471. doi:10.1001/jamaoncol.2016.519427978560
   PubMed Web of Science ®Google Scholar
• Yurgelun MB, Kulke MH, Fuchs CS, et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol. 2017;35(10):1086–1095. doi:10.1200/JCO.2016.71.001228135145
   PubMed Web of Science ®Google Scholar
• Yurgelun MB, Allen B, Kaldate RR, et al. Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome. Gastroenterology. 2015;149(3):604–13.e20. doi:10.1053/j.gastro.2015.05.00625980754
   PubMed Web of Science ®Google Scholar
• Gallego CJ, Shirts BH, Bennette CS, et al. Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: a cost-effectiveness analysis. J Clin Oncol. 2015;33(18):2084–2091. doi:10.1200/JCO.2014.59.366525940718
   PubMed Web of Science ®Google Scholar
• Susswein LR, Marshall ML, Nusbaum R, et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med. 2016;18(8):823–832. doi:10.1038/gim.2015.16626681312
   PubMed Web of Science ®Google Scholar
• Hahn MM, de Voer RM, Hoogerbrugge N, Ligtenberg MJL, Kuiper RP, van Kessel AG. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery. Cell Oncol (Dordr). 2016;39(6):491–510. doi:10.1007/s13402-016-0284-627279102
   PubMed Web of Science ®Google Scholar
• Sue Richards NAPS. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;5(17):405–423. doi:10.1038/gim.2015.30
   Google Scholar
• Casper J, Zweig AS, Villarreal C, et al. The UCSC Genome Browser database: 2018 update. Nucleic Acids Res. 2018;46(D1):D762–D769. doi:10.1093/nar/gkx102029106570
   PubMed Web of Science ®Google Scholar
• Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–1081. doi:10.1038/nprot.2009.8619561590
   PubMed Web of Science ®Google Scholar
• Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–249. doi:10.1038/nmeth0410-24820354512
   PubMed Web of Science ®Google Scholar
• Trojan J, Zeuzem S, Randolph A, et al. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology. 2002;122(1):211–219. 11781295
   PubMed Web of Science ®Google Scholar
• Stoffel EM, Koeppe E, Everett J, et al. Germline genetic features of young individuals with colorectal cancer. Gastroenterology. 2018;154(4):897–905.e1. doi:10.1053/j.gastro.2017.11.00429146522
   PubMed Web of Science ®Google Scholar
• Barnetson RA, Tenesa A, Farrington SM, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354(26):2751–2763. doi:10.1056/NEJMoa05349316807412
   PubMed Web of Science ®Google Scholar
• Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26(35):5783–5788. doi:10.1200/JCO.2008.17.595018809606
   PubMed Web of Science ®Google Scholar
• Ward RL, Hicks S, Hawkins NJ. Population-based molecular screening for Lynch syndrome: implications for personalized medicine. J Clin Oncol. 2013;31(20):2554–2562. doi:10.1200/JCO.2012.46.845423733757
   PubMed Web of Science ®Google Scholar
• Moreira L, Balaguer F, Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012;308(15):1555–1565. doi:10.1001/jama.2012.1308823073952
   PubMed Web of Science ®Google Scholar
• Kastrinos F, Ojha RP, Leenen C, et al. Comparison of prediction models for Lynch syndrome among individuals with colorectal cancer. J Natl Cancer Inst. 2016;108(2):djv308. doi:10.1093/jnci/djv30826582061
   PubMedGoogle Scholar
• Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223–262. quiz 263 DOI:10.1038/ajg.2014.435. 25645574
   PubMed Web of Science ®Google Scholar
• Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol. 2014;109(8):1159–1179. doi:10.1038/ajg.2014.18625070057
   PubMed Web of Science ®Google Scholar
• Hu C, Hart SN, Polley EC, et al. Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA. 2018;319(23):2401–2409. doi:10.1001/jama.2018.622829922827
   PubMed Web of Science ®Google Scholar
• Ma X, Zhang B, Zheng W. Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Gut. 2014;63(2):326–336. doi:10.1136/gutjnl-2012-30412123946381
   PubMed Web of Science ®Google Scholar
• Kondo E, Horii A, Fukushige S. The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2. Nucleic Acids Res. 2001;29(8):1695–1702. 11292842
   PubMed Web of Science ®Google Scholar
• Guerrette S, Acharya S, Fishel R. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem. 1999;274(10):6336–6341. 10037723
   PubMed Web of Science ®Google Scholar